Analyst Price Target is $3.00
▲ +1,089.53% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Mainz Biomed in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 1,089.53% upside from the last price of $0.25.
Current Consensus is
Moderate Buy
The current consensus among 2 investment analysts is to moderate buy stock in Mainz Biomed. This Moderate Buy consensus rating has held steady for over two years.